Olema Pharmaceuticals, Inc.
OLMA
$27.54
$0.391.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.58% | -44.08% | 9.47% | 2.86% | -13.74% |
| Total Depreciation and Amortization | -67.42% | 3.13% | 10.34% | 22.11% | 1.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.16% | 27.42% | -48.63% | 27.55% | 2.43% |
| Change in Net Operating Assets | -57.93% | 164.50% | -848.25% | -38.37% | 424.84% |
| Cash from Operations | -15.54% | 32.05% | -67.32% | 2.71% | 1.96% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.54% | 175.94% | 60.60% | -349.18% | 1,042.53% |
| Cash from Investing | -49.54% | 175.94% | 60.60% | -349.18% | 1,041.37% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.82% | 316.10% | -99.91% | 272,506.52% | -99.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -46,328.57% | 99.78% | -- | -- |
| Cash from Financing | 101.63% | -1,234.23% | -99.91% | 265,443.48% | -99.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,039.06% | 102.06% | -185.76% | 445.34% | 212.88% |